DefendSphere Secures $385

KnowTransfer

At KnowTransfer, we're passionate about nurturing the future of innovation! We bridge the gap between groundbreaking research and market success, empowering tech-based companies, universities, and research centers to thrive. From validating new technologies to securing funding and connecting talent, we're here to grow the innovation ecosystem. Discover how KnowTransfer accelerates impact! #KnowTransfer #InnovationEcosystem #TechCommercialization

VIOLET Pharmaceuticals

VIOLET Pharmaceuticals is a preclinical stage biopharma company developing a First-in-Class mRNA therapy against metastatic cancers. The company develops nanotherapies improving immunotherapies’ efficiency and approved indications (e.g. Immune Checkpoints Inhibitors (ICI)) by increasing the whole Antigen Presentation Machinery (APM) in tumor cells. Our mRNA technology is backed by Top-Notch science published in leading journals such as Nature Cell Biology and Nature Cancer, and has a strong IP position (3 patents). We achieved radical complete responses with our mRNA NanoTherapy in combination with ICI in several breast cancer tumors and metastasis models. Our mRNA specifically modulates the whole Antigen Presentation Machinery which determines immune detection (tumor visibility) and immunotherapy response. There are currently no specific APM-modulating therapies on the market, only competitors with indirect APM modulation. Therefore, our patented mRNA therapy emerges as a critical therapeutic partner to make tumor cells visible and vulnerable to immunotherapies. VIOLET Pharmaceuticals : Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies

Nexyra Advanced Research

Multi-omics intelligence for precision medicine. We accelerate biotech and precision medicine innovation through advanced bioinformatics, multi-omics intelligence and AI-powered asset evaluation. Nexyra helps biotech, pharma, investors and business development teams transform complex molecular, clinical and competitive evidence into decision-ready insights—supporting R&D optimization, therapeutic asset evaluation, biomarker discovery, target prioritization and me-too / me-better strategy with greater speed, rigor and confidence.

AITA

AITA World is the AI-powered execution engine for clean energy projects — from idea to operating asset. We exist to close the gap between clean energy ambition and delivery by automating the execution layer that slows projects down and keeps capital on the sidelines. The AITA ecosystem brings together three layers: → a digital core that automates engineering, procurement, and SPV structuring → an operational network connecting developers, EPCs, suppliers, and agents → a capital layer that structures and monitors clean energy assets for investors Through this, we take a project from initial submission through automated engineering, financing, procurement coordination, and real-time asset management — removing the fragmentation that makes clean energy development slow and opaque. We work across solar, BESS, EV charging, and hybrid infrastructure. Clean energy. Executed. ? Follow us for insights into green energy innovations, investments, and AI-driven energy market transformation.

IMPETUX OPTICS S.L.

The distinctive optical manipulation technology developed and commercialized by IMPETUX provides unprecedented power and ease of use for experiments in cell mechanics: Calibration-free force measurements in living cells Active microrheology measurements in multiple spots Automated routines for cell mechanics studies Compatible with phase contrast, DIC or fluorescence Force measurements in tissues (0.5 mm thickness) High efficiency trapping* for low cell damage Maximum control of laser power at sample * Factor 2-3 compared to traditional technology. Our laser tweezers platform is composed by two units: the optical manipulation module for the trapping and motion of microscopic samples, and the force sensor module for the measurement of the biological forces involved in the experiment.